Next Article in Journal
The igf System in Carcinogenesis and Its Implication for Cancer Therapy
Previous Article in Journal
A Prospective Pilot Study Investigating the Musculoskeletal Pain in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitor Therapy
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Meeting Report

First Annual Canadian Cardiac Oncology Network Conference

1
The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
2
The University of Ottawa, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(6), 295-300; https://doi.org/10.3747/co.v18i6.968
Submission received: 7 November 2011 / Revised: 8 November 2011 / Accepted: 14 November 2011 / Published: 1 December 2011

Abstract

The inaugural Canadian Cardiac Oncology Network conference was held at the Ottawa Convention Centre, Ottawa, Ontario, May 13, 2011. The learning objectives of the meeting were to: 1. understand and appreciate the importance of cardiac toxicity in the treatment of cancer patients; 2 review current guidelines, recommendations, and ways to prevent and treat cardiac toxicity in cancer patients; 3 develop potential research initiatives and collaboration across Canada. Although the cardiac toxicities associated with conventional systemic therapy agents are well established, the short- and long-term cardiac toxicities associated with targeted agents are less understood. In addition, the effects of exposing patients to multiple targeted therapies, and potentially compounding multiple cardiac toxicities, are unknown. This meeting report includes highlights from presentations at the conference.
Keywords: cancer treatment; targeted therapies; cardiac health; cardiac toxicities; solid malignancies cancer treatment; targeted therapies; cardiac health; cardiac toxicities; solid malignancies

Share and Cite

MDPI and ACS Style

Dent, S.F.; Graham, N.A. First Annual Canadian Cardiac Oncology Network Conference. Curr. Oncol. 2011, 18, 295-300. https://doi.org/10.3747/co.v18i6.968

AMA Style

Dent SF, Graham NA. First Annual Canadian Cardiac Oncology Network Conference. Current Oncology. 2011; 18(6):295-300. https://doi.org/10.3747/co.v18i6.968

Chicago/Turabian Style

Dent, S.F., and N.A. Graham. 2011. "First Annual Canadian Cardiac Oncology Network Conference" Current Oncology 18, no. 6: 295-300. https://doi.org/10.3747/co.v18i6.968

APA Style

Dent, S. F., & Graham, N. A. (2011). First Annual Canadian Cardiac Oncology Network Conference. Current Oncology, 18(6), 295-300. https://doi.org/10.3747/co.v18i6.968

Article Metrics

Back to TopTop